TrialBMC pharmacology & toxicology2023

Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.

Benthe A M Dijkman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.